Unveiling the Link Between Chronic Inflammation and Cancer
Siddhant Tripathi,
No information about this author
Yashika Sharma,
No information about this author
Dileep Kumar
No information about this author
et al.
Metabolism Open,
Journal Year:
2025,
Volume and Issue:
25, P. 100347 - 100347
Published: Jan. 9, 2025
The
highly
nuanced
transition
from
an
inflammatory
process
to
tumorigenesis
is
of
great
scientific
interest.
While
it
well
known
that
environmental
stimuli
can
cause
inflammation,
less
about
the
oncogenic
modifications
chronic
inflammation
in
tissue
microenvironment
bring
about,
as
how
these
set
off
pro-tumorigenic
processes.
It
clear
no
matter
where
factors
come
from,
maintaining
encourages
carcinogenesis.
In
addition
encouraging
angiogenesis
and
metastatic
processes,
sustaining
survival
proliferation
malignant
transformed
cells,
possibly
altering
efficacy
therapeutic
agents,
negatively
regulate
antitumoral
adaptive
innate
immune
responses.
Because
has
multiple
pathways
involved
metastasis,
gained
recognition
a
marker
cancer
desirable
target
for
therapy.
Recent
advances
our
knowledge
molecular
mechanisms
drive
cancer's
progression
demonstrate
promotes
metastasis
while
suppressing
anti-tumor
immunity.
many
solid
tumor
types,
including
breast,
lung,
liver
cancer,
stimulates
activation
oncogenes
impairs
body's
defenses
against
tumor.
Additionally,
alters
As
tactical
approach
treatment,
findings
have
underscored
importance
targeting
pathways.
This
review
highlights
role
development
focusing
on
its
impact
progression,
suppression,
therapy
resistance.
examines
current
anti-inflammatory
strategies,
NSAIDs,
cytokine
modulators,
STAT3
inhibitors,
addressing
their
potential
limitations.
emphasizes
need
further
research
unravel
complex
linking
identify
targets
specific
subtypes.
Language: Английский
Theoretical Framework and Emerging Challenges of Lipid Metabolism in Cancer
Seminars in Cancer Biology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 1, 2024
Elevated
lipid
metabolism
is
one
of
hallmarks
malignant
tumors.
Lipids
not
only
serve
as
essential
structural
components
biological
membranes
but
also
provide
energy
and
substrates
for
the
proliferation
cancer
cells
tumor
growth.
Cancer
meet
their
needs
by
coordinating
processes
absorption,
synthesis,
transport,
storage,
catabolism.
As
research
in
this
area
continues
to
deepen,
numerous
new
discoveries
have
emerged,
making
it
crucial
scientists
stay
informed
about
developments
metabolism.
In
review,
we
first
discuss
relevant
concepts
theories
or
assumptions
that
help
us
understand
-based
therapies.
We
then
systematically
summarize
latest
advancements
including
mechanisms,
novel
targets,
up-to-date
pre-clinical
clinical
investigations
anti-cancer
treatment
with
targeted
drugs.
Finally,
emphasize
emerging
directions
therapeutic
strategies,
future
prospective
challenges.
This
review
aims
insights
guidance
field
Language: Английский
Noncoding RNA-encoded peptides in cancer: biological functions, posttranslational modifications and therapeutic potential
Shiming Tan,
No information about this author
Wenjuan Yang,
No information about this author
Zongyao Ren
No information about this author
et al.
Journal of Hematology & Oncology,
Journal Year:
2025,
Volume and Issue:
18(1)
Published: Feb. 19, 2025
In
the
present
era,
noncoding
RNAs
(ncRNAs)
have
become
a
subject
of
considerable
scientific
interest,
with
peptides
encoded
by
ncRNAs
representing
particularly
promising
avenue
investigation.
The
identification
ncRNA-encoded
in
human
cancers
is
increasing.
These
regulate
cancer
progression
through
multiple
molecular
mechanisms.
Here,
we
delineate
patterns
diverse
and
provide
synopsis
methodologies
employed
for
that
possess
capacity
to
encode
these
peptides.
Furthermore,
discuss
impacts
on
biological
behavior
cells
underlying
conclusion,
describe
prospects
challenges
need
be
overcome.
Language: Английский
The role of miRNAs in the extracellular vesicle-mediated interplay between breast tumor cells and cancer-associated fibroblasts
Journal of Cancer Metastasis and Treatment,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 27, 2024
The
tumor
microenvironment
(TME)
of
breast
cancer
(BC)
is
depicted
as
an
immunosuppressive
dwelling
that
comprises
a
myriad
cell
types
embedded
in
the
extracellular
matrix.
As
one
most
abundant
populations
within
TME,
cancer-associated
fibroblasts
(CAFs)
play
indispensable
roles
increasing
aggressiveness
and
promoting
resistance
to
standard-of-care
therapies.
Extracellular
vesicles
(EVs)
represent
diverse
array
biological
nanoparticles,
encompassing
exosomes,
microvesicles,
apoptotic
bodies.
In
recent
years,
these
cell-derived
membranous
structures
have
raised
great
interest
they
can
encapsulate
numerous
cellular
cargo,
such
proteins,
lipids,
miRNAs.
By
transmitting
bioactive
content
recipient
cells,
EVs
pivotal
intercellular
communication
between
CAFs
cells.
secreted
from
cells
typically
activate
resident
acquire
myofibroblastic
phenotype,
while
diffused
by
CAFs,
turn,
substantially
increase
progression
BC.
This
review
summarizes
latest
findings
highlight
functional
role
EV
especially
miRNAs,
regulatory
network.
A
better
understanding
EV-mediated
cell-cell
interactions
crucial
achieving
effective
treatment
patients
with
Language: Английский